(JIGB) JPMorgan Corporate Bond - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US46641Q4495 • Corporate Bond
JIGB: Investment, Grade, Corporate, Debt, Securities, Bonds, U.S
The JPMorgan Corporate Bond Research Enhanced ETF (JIGB) is designed to provide exposure to U.S. dollar-denominated investment-grade corporate debt. The fund invests at least 80% of its assets in securities included in its underlying index, which is market capitalization-weighted and tracks the performance of publicly issued corporate debt in the U.S. domestic market. The index is a subset of the broader Bloomberg US Credit and Bloomberg US Aggregate indices, focusing on higher-quality debt securities.
The funds underlying index includes a diverse range of corporate bonds issued by U.S. companies, offering exposure to various sectors and maturities. The market capitalization weighting ensures that larger issuers have a greater influence on the indexs performance. This approach aligns with traditional fixed-income indexing but incorporates enhancements to optimize returns and reduce risk.
From a technical perspective, JIGB exhibits low average daily trading volume of 6,553 shares over the past 20 days, indicating limited liquidity. The funds price of $45.46 is slightly above its 20-day SMA of $45.23 but closely aligned with its 50-day SMA of $44.83 and 200-day SMA of $44.75. This suggests a consolidative price pattern with minimal upward bias. The ATR of 0.17 reflects low volatility, consistent with investment-grade corporate bonds.
Fundamentally, JIGB manages assets under management (AUM) of $43.29 million, positioning it as a smaller ETF in the corporate bond category. This modest size may limit its trading activity but allows for targeted exposure to the U.S. investment-grade corporate debt market.
Over the next three months, JIGB is expected to trade within a narrow range, supported by its tight ATR and converging SMAs. The funds price is likely to remain stable, oscillating between $45.00 and $46.00, as the low volatility and limited trading activity suggest minimal directional movement. The funds performance will closely track the underlying index, with returns driven by interest rate fluctuations and credit spreads in the U.S. investment-grade corporate bond market.
Additional Sources for JIGB ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
JIGB ETF Overview
Market Cap in USD | 38m |
Category | Corporate Bond |
TER | 0.09% |
IPO / Inception | 2018-12-12 |
JIGB ETF Ratings
Growth Rating | -3.87 |
Fundamental | - |
Dividend Rating | 50.8 |
Rel. Strength | 3.59 |
Analysts | - |
Fair Price Momentum | 43.22 USD |
Fair Price DCF | - |
JIGB Dividends
Dividend Yield 12m | 3.82% |
Yield on Cost 5y | 3.90% |
Annual Growth 5y | -0.43% |
Payout Consistency | 81.9% |
JIGB Growth Ratios
Growth Correlation 3m | -16.3% |
Growth Correlation 12m | 50.1% |
Growth Correlation 5y | -49.5% |
CAGR 5y | 0.45% |
CAGR/Max DD 5y | 0.02 |
Sharpe Ratio 12m | 0.44 |
Alpha | 0.47 |
Beta | 0.033 |
Volatility | 8.12% |
Current Volume | 1.4k |
Average Volume 20d | 2.8k |
As of May 09, 2025, the stock is trading at USD 44.82 with a total of 1,379 shares traded.
Over the past week, the price has changed by -0.02%, over one month by +1.74%, over three months by +0.49% and over the past year by +5.19%.
Neither. Based on ValueRay Analyses, JPMorgan Corporate Bond is currently (May 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of -3.87 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of JIGB as of May 2025 is 43.22. This means that JIGB is currently overvalued and has a potential downside of -3.57%.
JPMorgan Corporate Bond has no consensus analysts rating.
According to ValueRays Forecast Model, JIGB JPMorgan Corporate Bond will be worth about 46.7 in May 2026. The stock is currently trading at 44.82. This means that the stock has a potential upside of +4.15%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 46.7 | 4.1% |